Filter your results
- 2
- 1
- 3
- 3
- 62
- 39
- 39
- 21
- 1
- 1
- 1
- 3
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Disability Progression in Multiple Sclerosis Patients using Early First-line TreatmentsEuropean Journal of Neurology, 2022, 29 (9), pp.2761-2771. ⟨10.1111/ene.15422⟩
Journal articles
hal-03690316v1
|
||
|
Long‐term effect of first‐line injectable multiple sclerosis treatments: input of a time‐dependent propensity scorePharmacoepidemiology and Drug Safety, 2020, 29 (12), pp.1680-1688. ⟨10.1002/pds.5154⟩
Journal articles
hal-02979802v1
|
||
A new treatment era in multiple sclerosis: Clinical applications of new conceptsJournal of the Neurological Sciences, 2011, 306 (1-2), pp.170-172. ⟨10.1016/j.jns.2010.09.018⟩
Journal articles
istex
hal-02437067v1
|